Barclays’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
297,692
+66,702
| +29% | +$48.8K | ﹤0.01% | 3473 |
|
|
2025
Q1 | $186K | Sell |
230,990
-69,202
| -23% | -$55.7K | ﹤0.01% | 3370 |
|
|
2024
Q4 | $414K | Sell |
300,192
-2,166,113
| -88% | -$2.99M | ﹤0.01% | 3169 |
|
|
2024
Q3 | $2.56M | Buy |
2,466,305
+275,784
| +13% | +$287K | ﹤0.01% | 2000 |
|
|
2024
Q2 | $3.79M | Buy |
2,190,521
+125,170
| +6% | +$217K | ﹤0.01% | 1314 |
|
|
2024
Q1 | $4.94M | Sell |
2,065,351
-1,419,044
| -41% | -$3.39M | ﹤0.01% | 1384 |
|
|
2023
Q4 | $11.6M | Buy |
3,484,395
+1,108,838
| +47% | +$3.69M | ﹤0.01% | 974 |
|
|
2023
Q3 | $8.88M | Buy |
2,375,557
+2,301,444
| +3,105% | +$8.61M | 0.01% | 903 |
|
|
2023
Q2 | $317K | Sell |
74,113
-114,403
| -61% | -$489K | ﹤0.01% | 2852 |
|
|
2023
Q1 | $1.29M | Sell |
188,516
-110,490
| -37% | -$756K | ﹤0.01% | 1955 |
|
|
2022
Q4 | $2.37M | Buy |
299,006
+94,202
| +46% | +$746K | ﹤0.01% | 1535 |
|
|
2022
Q3 | $1.97M | Buy |
204,804
+162,448
| +384% | +$1.56M | ﹤0.01% | 1671 |
|
|
2022
Q2 | $308K | Sell |
42,356
-12,104
| -22% | -$88K | ﹤0.01% | 2885 |
|
|
2022
Q1 | $705K | Sell |
54,460
-42,230
| -44% | -$547K | ﹤0.01% | 2561 |
|
|
2021
Q4 | $1.54M | Sell |
96,690
-35,533
| -27% | -$567K | ﹤0.01% | 1942 |
|
|
2021
Q3 | $2.13M | Buy |
132,223
+24,757
| +23% | +$398K | ﹤0.01% | 1828 |
|
|
2021
Q2 | $1.49M | Sell |
107,466
-41,118
| -28% | -$569K | ﹤0.01% | 1894 |
|
|
2021
Q1 | $2.17M | Sell |
148,584
-494,432
| -77% | -$7.22M | ﹤0.01% | 1792 |
|
|
2020
Q4 | $11.2M | Buy |
643,016
+301,709
| +88% | +$5.24M | 0.01% | 754 |
|
|
2020
Q3 | $6.26M | Buy |
341,307
+56,394
| +20% | +$1.03M | ﹤0.01% | 874 |
|
|
2020
Q2 | $5.09M | Sell |
284,913
-124,055
| -30% | -$2.22M | ﹤0.01% | 933 |
|
|
2020
Q1 | $6.63M | Buy |
408,968
+333,856
| +444% | +$5.41M | 0.01% | 764 |
|
|
2019
Q4 | $1.35M | Sell |
75,112
-12,108
| -14% | -$218K | ﹤0.01% | 2118 |
|
|
2019
Q3 | $1.77M | Buy |
87,220
+47,315
| +119% | +$959K | ﹤0.01% | 1857 |
|
|
2019
Q2 | $882K | Buy |
39,905
+19,622
| +97% | +$434K | ﹤0.01% | 2418 |
|
|
2019
Q1 | $276K | Buy |
20,283
+17,687
| +681% | +$241K | ﹤0.01% | 2889 |
|
|
2018
Q4 | $23K | Sell |
2,596
-76,975
| -97% | -$682K | ﹤0.01% | 3349 |
|
|
2018
Q3 | $1.31M | Buy |
79,571
+56,954
| +252% | +$939K | ﹤0.01% | 2091 |
|
|
2018
Q2 | $317K | Buy |
22,617
+12,245
| +118% | +$172K | ﹤0.01% | 2519 |
|
|
2018
Q1 | $115K | Buy |
10,372
+2,793
| +37% | +$31K | ﹤0.01% | 3107 |
|
|
2017
Q4 | $67K | Sell |
7,579
-1,060
| -12% | -$9.37K | ﹤0.01% | 3210 |
|
|
2017
Q3 | $115K | Sell |
8,639
-13,008
| -60% | -$173K | ﹤0.01% | 2650 |
|
|
2017
Q2 | $311K | Buy |
21,647
+3,136
| +17% | +$45.1K | ﹤0.01% | 2179 |
|
|
2017
Q1 | $391K | Buy |
18,511
+16,302
| +738% | +$344K | ﹤0.01% | 2104 |
|
|
2016
Q4 | $62K | Sell |
2,209
-2,594
| -54% | -$72.8K | ﹤0.01% | 2756 |
|
|
2016
Q3 | $129K | Buy |
4,803
+4,186
| +678% | +$112K | ﹤0.01% | 2337 |
|
|
2016
Q2 | $10K | Buy |
617
+342
| +124% | +$5.54K | ﹤0.01% | 2980 |
|
|
2016
Q1 | $6K | Sell |
275
-443
| -62% | -$9.67K | ﹤0.01% | 3025 |
|
|
2015
Q4 | $16K | Buy |
718
+595
| +484% | +$13.3K | ﹤0.01% | 2734 |
|
|
2015
Q3 | $2K | Sell |
123
-329
| -73% | -$5.35K | ﹤0.01% | 3489 |
|
|
2015
Q2 | $13K | Buy |
452
+244
| +117% | +$7.02K | ﹤0.01% | 3161 |
|
|
2015
Q1 | $7K | Sell |
208
-180
| -46% | -$6.06K | ﹤0.01% | 3524 |
|
|
2014
Q4 | $6K | Buy |
+388
| New | +$6K | ﹤0.01% | 3898 |
|